An international research team with strong participation from DTU has developed a new biotechnological platform that makes it possible to test and understand advanced cancer treatments much faster and cheaper than before
I still vividly remember the first time we observed neurons responding not to audible sound, but to concentrated, precisely calibrated ultrasonic pulses.
A patient with complete blindness caused by irreversible optic nerve damage partially recovered natural vision after participating in a clinical trial of electrical stimulation of the visual cortex conducted by researchers.
Two models more accurately replicate the physiology of the liver, offering a new way to test treatments for fat buildup.
WITEC is working to develop the first wearable ultrasound imaging system to monitor chronic conditions in real-time, with the goal of enabling earlier detection and timely intervention.
Quest expects the new blood test will support response monitoring in clinical trials.
RevealDX’s software analyses CT scans and assigns lung nodules with a Malignancy Similarity Index score to aid in lung cancer diagnosis.
Johnson & Johnson MedTech (NYSE: JNJ)+
today announced the full commercial release of its NuVision Nav ultrasound catheter.
A research team led by La Trobe University has developed a single-use test strip that could ultimately change how diseases like cancer are diagnosed. The research used enzymes to boost an electrical signal to detect disease-indicative molecules, also known as microRNAs.
Scientists at Université de Montréal and its affiliated Centre de recherche Azrieli du CHU Sainte-Justine have made a major advance in their research into cardiovascular disease: They’ve created functional, three-dimensional heart tissue that can beat autonomously in vitro.